Novartis Officially Opens $1 Billion Vaccine Manufacturing Plant in North Carolina
12/13/2011
The plant's opening marks the first change in influenza vaccine manufacturing in the United States in 50 years. Specifically, it's the first American plant capable of quickly producing pandemic and seasonal influenza vaccines using cultured animal cells rather than fertilized eggs. This new cell-based technology also may be adapted to produce large amounts of vaccines for other emerging infectious diseases.
Located on 167 acres, the Holly Springs site consists of six connected buildings comprising 430,000 square feet of manufacturing, laboratory and office space. Novartis employs about 400 colleagues here, and has plans to expand to 500 workers by year-end 2012.
"The pandemic readiness of this facility is a major milestone in national preparedness for pandemic influenza and other diseases," noted Robin Robinson, Ph.D., director of the Biomedical Advanced Research and Development Authority (BARDA) associated with HHS. Officials estimate it might be capable of producing one-fourth of the vaccine needed in America during an influenza pandemic. Relatedly, North Carolina State University is working with Novartis and BARDA to educate scientists from around the world about the plant's advanced manufacturing processes. This training should further advance efforts to stem regional and global spreading of deadly illnesses, both known and unknown.
Project Announcements
Canfor Expands Fulton, Alabama, Production Operations
04/22/2024
Tucker Door & Trim Plans Henrico County, Virginia, Operations
04/19/2024
Zekelman Industries Expands Blytheville, Arkansas, Operations
04/19/2024
Fibrebond Corporation Expands Webster Parish, Louisiana, Operations
04/19/2024
Master Steel Expands Hardeeville, South Carolina, Operations
04/19/2024
L3Harris Technologies Expands Orange County, Virginia, Operations
04/18/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024